SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 222 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $222,715 | -26.9% | 7,409 | -11.9% | 0.01% | -37.5% |
| Q1 2023 | $304,549 | +10.7% | 8,406 | +9.0% | 0.01% | +14.3% |
| Q4 2022 | $275,051 | -8.6% | 7,711 | -13.2% | 0.01% | 0.0% |
| Q3 2022 | $301,000 | +157.3% | 8,886 | +122.2% | 0.01% | +600.0% |
| Q4 2021 | $117,000 | -89.5% | 4,000 | -90.5% | 0.00% | -90.9% |
| Q3 2021 | $1,119,000 | -36.5% | 41,962 | -26.7% | 0.01% | -35.3% |
| Q2 2021 | $1,763,000 | +4000.0% | 57,251 | +3246.1% | 0.02% | +1600.0% |
| Q4 2020 | $43,000 | -96.9% | 1,711 | -97.4% | 0.00% | -96.2% |
| Q3 2020 | $1,379,000 | – | 66,177 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
| Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
| KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
| AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
| Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
| Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
| Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
| SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
| Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |